B56.0 Gambiense trypanosomiasis

Name of the Condition

• Gambiense trypanosomiasis

Summary

Gambiense trypanosomiasis is a vector-borne parasitic disease caused by Trypanosoma brucei gambiense. It progresses through distinct stages, with early systemic symptoms and later central nervous system involvement. Endemic to sub-Saharan Africa, it is transmitted primarily by tsetse flies and represents the chronic form of African trypanosomiasis.

Causes

The disease results from infection with Trypanosoma brucei gambiense parasites. Transmission occurs via the bite of infected tsetse flies, which introduce the parasites into the bloodstream. The parasites multiply and spread, eventually crossing the blood-brain barrier in later stages.

Risk Factors

• Residence in or travel to endemic regions of sub-Saharan Africa.
• Prolonged outdoor exposure in rural areas where tsetse flies are prevalent.
• Lack of protective measures against insect bites, such as insect repellent or clothing.
• Occupational activities involving contact with tsetse fly habitats, such as farming or hunting.
• Immunocompromised states may increase susceptibility to severe disease.

Symptoms

• Initial stage: Fever, headache, joint pain, and itching at the bite site (chancre).
• Swollen lymph nodes, particularly in the posterior cervical region (Winterbottom's sign).
• Progressive fatigue, weight loss, and intermittent fevers.
• Later stages: Neurological symptoms, including confusion, personality changes, and sleep disturbances.

Diagnosis

Diagnosis involves clinical evaluation, microscopic examination of blood or lymph node aspirates for parasites, and serological tests. Cerebrospinal fluid analysis is used to assess central nervous system involvement. Polymerase chain reaction (PCR) may be employed for confirmation.

Treatment Options

Treatment depends on disease stage. Early-stage disease is treated with pentamidine or suramin. Late-stage disease requires more toxic drugs, such as melarsoprol or eflornithine, often in combination regimens. Supportive care addresses symptoms and complications.

Prognosis and Follow-Up

Prognosis is favorable with early diagnosis and treatment. Untreated late-stage disease is often fatal. Follow-up includes monitoring for treatment response, neurological status, and potential relapse. Long-term surveillance may be necessary for chronic cases.

Complications

• Neurological damage, including cognitive impairment and motor dysfunction.
• Cardiac complications, such as myocarditis.
• Secondary infections due to immunosuppression.
• Severe anemia and organ failure in advanced cases.

Lifestyle & Prevention

• Avoid travel to endemic areas or use protective measures if unavoidable.
• Wear long-sleeved clothing and insect repellent in tsetse fly habitats.
• Sleep under insecticide-treated nets.
• Screen blood donations from endemic regions to prevent transfusion-related transmission.

When to Seek Professional Help

Seek medical attention if experiencing fever, headache, or unexplained fatigue after travel to sub-Saharan Africa. Prompt evaluation is critical for early diagnosis and treatment to prevent progression to severe disease.

Tips for Medical Coders

Document the presence of neurological involvement, treatment stage, and any complications to support accurate coding. Ensure clinical documentation specifies whether the condition is early or late stage, as this impacts code assignment.